Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-07-18

Clinical Trial Update: Utility of Bowel Ultrasound in Diagnosing Necrotizing Eneterocolitis in Congenital Heart Disease [NA]

View source ↗

Summary

A clinical trial investigating bowel ultrasound for diagnosing necrotizing enterocolitis in patients with congenital heart disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Enterocolitis, Necrotizing, Congenital Heart Disease | NA | Status: WITHDRAWN